Gilead, Teva Ink 11th-Hour HIV Antitrust Deal With Pharmacies

By Bonnie Eslinger (May 25, 2023, 2:47 PM EDT) -- With openings set to begin Thursday in an antitrust trial over claims Gilead and Teva illegally inflated HIV drug prices, the two drugmakers struck a last-minute deal with major pharmacies, and Gilead settled with direct purchasers — leaving indirect purchasers and others to take their claims to a California federal jury....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!